BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy.

Source:http://linkedlifedata.com/resource/pubmed/id/18559524

Cancer Res. 2008 Jun 15 68 12 4774-82

Download in:

View as

General Info

PMID
18559524